EMEND 150 mg/5mL

Fosaprepitant dimeglumine is a lyophilized powder for injection used to prevent nausea and vomiting. This antiemetic is often administered intravenously for chemotherapy-induced nausea and vomiting (CINV).

Fosaprepitant dimeglumine is primarily used to prevent nausea and vomiting caused by chemotherapy. It is a neurokinin-1 (NK-1) receptor antagonist, which helps manage CINV. Patients often use this medication as part of a combination therapy to enhance its effectiveness. What is fosaprepitant dimeglumine used for? It is typically prescribed for patients undergoing chemotherapy to alleviate symptoms of nausea and vomiting.

Common effects of fosaprepitant dimeglumine may include fatigue, headache, and diarrhea. Some patients might experience changes in taste or appetite. These effects are generally mild and temporary, but severe reactions are possible and should be reported to a healthcare provider.

Fosaprepitant dimeglumine should be handled with care, as it is a potent medication. It is important to follow the prescribed dosage and administration instructions. Patients with a history of severe allergic reactions to similar medications should inform their healthcare provider before use. Proper storage and handling are crucial to maintain the medication's efficacy.

Fosaprepitant dimeglumine may interact with other medications, including CYP3A4 inhibitors and inducers. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect the medication's effectiveness, so it is advisable to follow your healthcare provider's guidelines.